26 results
IBD Innovate: Patients as medical entrepreneurs
The following are two patient stories that were recently presented at the Crohn's & Colitis Foundation's second annual IBD Innovate Conference. They demonstrate how patients are taking active roles in creating new products to help IBD patients.
Crohn’s patient Slawa Madelska and Dr. Christian...
Read more... IBD Innovate: Accelerating IBD products through innovation
At the end of 2019, the Crohn’s & Colitis Foundation convened the second annual IBD Innovate, our unique showcase and networking event for innovators working in the inflammatory bowel disease (IBD) space.
By bringing together developers engaged in the creation of new and innovati...
Read more... Mental Health—An invisible driver of IBD cost of care
Living with a chronic illness, like Crohn’s disease or ulcerative colitis, can affect not only your physical health but also your mental health and emotional well-being. In fact, the rate of anxiety and depression among IBD patients is two to three times higher than that of the general population.
...
Read more... The Weekend Effect: Risks for Pediatric IBD Patients
Have you ever noticed that your quality of treatment in a hospital changes based on the time of day and/or the day of the week that you are there? It’s true; the care you receive during regular hours on a weekday can vary drastically from the weekend. This is often referred to as the weekend effect—...
Read more... Q&A with Dr. Meena Bewtra, IBD Patient and Researcher
March is Women’s History Month. The Crohn’s & Colitis Foundation would like to take this opportunity to put the spotlight on some of the fearless women leaders committed to making a difference for IBD patients. For this edition, Cecile Norris, Senior Research Manager at the Foundation, interview...
Read more... Guest Author Dr. Zhu Shares An Update on Recent Study Examining the Treatment of IBD by Targeting Microbes
In recent years, it has been increasingly recognized that the microbes which inhabit the intestinal tract, termed microbiota, have a profound impact on IBD. These microbes are essential to human health, but can become a liability during inflammatory gut disorders. Targeting these microbes via novel ...
Read more...